- Home
- GRVY vs KMDA Comparison
GRVY vs KMDA Comparison
Compare GRVY & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GRVY | KMDA |
|---|---|---|
| Founded | 2000 | 1990 |
| Country | South Korea | Israel |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 399.1M | 458.6M |
| IPO Year | 2005 | N/A |
Fundamental Metrics
Financial Performance| Metric | GRVY | KMDA |
|---|---|---|
| Price | $68.91 | $8.52 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $13.00 |
| AVG Volume (30 Days) | 29.6K | ★ 78.6K |
| Earning Date | 11-07-2025 | 03-04-2026 |
| Dividend Yield | N/A | ★ 2.33% |
| EPS Growth | N/A | ★ 30.41 |
| EPS | ★ 8.02 | 0.35 |
| Revenue | ★ $399,496,744.00 | $174,787,000.00 |
| Revenue This Year | N/A | $14.79 |
| Revenue Next Year | N/A | $11.38 |
| P/E Ratio | ★ $8.30 | $23.66 |
| Revenue Growth | ★ 12.13 | 10.36 |
| 52 Week Low | $53.12 | $5.54 |
| 52 Week High | $74.75 | $8.88 |
Technical Indicators
Market Signals| Indicator | GRVY | KMDA |
|---|---|---|
| Relative Strength Index (RSI) | 50.17 | 61.67 |
| Support Level | $68.00 | $7.94 |
| Resistance Level | $70.01 | $8.71 |
| Average True Range (ATR) | 3.80 | 0.24 |
| MACD | -0.70 | -0.01 |
| Stochastic Oscillator | 25.53 | 61.09 |
Price Performance
Historical ComparisonAbout GRVY GRAVITY Co. Ltd. American Depository Shares
GRAVITY Co Ltd is an online and mobile games developer and publisher based in Korea. Its principal product, Ragnarok Online, is an online game which is available in more than 91 markets. Its games include Ragnarok Online, Requiem, Dragonica (Dragon Saga), Ragnarok Online II, Requiem Online, and R.O.S.E. Online. The company generates revenue from online games, mobile games and other sources including character based merchandise and animation.
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.